ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,401.72
-0.77%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Creative Medical Technology Holdings Inc (CELZ)

  7. Creative Medical Technology Holdings Inc (CELZ) Noticias

CELZ

Creative Medical Technol... (CELZ)

Creative Medical Technology Holdings Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CELZ
FechaHoraFuenteTítuloSímboloCompañía
27/03/202408:00Business WireCreative Medical Technology Holdings Provides Corporate UpdateNASDAQ:CELZCreative Medical Technology Holdings Inc
07/03/202408:15Business WireCreative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded AccessNASDAQ:CELZCreative Medical Technology Holdings Inc
06/03/202415:10AllPennyStocks.comBiotech Finds Mid-Week Success Following FDA AnnouncementNASDAQ:CELZCreative Medical Technology Holdings Inc
06/03/202406:00Business WireCreative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation TherapyNASDAQ:CELZCreative Medical Technology Holdings Inc
20/12/202315:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELZCreative Medical Technology Holdings Inc
03/11/202315:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CELZCreative Medical Technology Holdings Inc
10/10/202307:00PR Newswire (US)Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back PainNASDAQ:CELZCreative Medical Technology Holdings Inc
19/09/202307:00PR Newswire (US)Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back PainNASDAQ:CELZCreative Medical Technology Holdings Inc
11/08/202315:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CELZCreative Medical Technology Holdings Inc
29/06/202316:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELZCreative Medical Technology Holdings Inc
29/06/202316:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CELZCreative Medical Technology Holdings Inc
28/06/202308:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CELZCreative Medical Technology Holdings Inc
28/06/202307:00PR Newswire (US)Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing RequirementsNASDAQ:CELZCreative Medical Technology Holdings Inc
12/06/202307:01PR Newswire (US)Creative Medical Technology Announces $2 Million Share Repurchase ProgramNASDAQ:CELZCreative Medical Technology Holdings Inc
09/06/202311:30PR Newswire (US)Creative Medical Technology Holdings Announces Reverse Stock SplitNASDAQ:CELZCreative Medical Technology Holdings Inc
31/05/202307:00PR Newswire (US)Creative Medical Technology Holdings Announces Successful Completion of the First Phase of its Program with Greenstone Biosciences, Inc. to Develop Next Generation iPSC Pipeline for ImmCelz® Immunotherapy PlatformNASDAQ:CELZCreative Medical Technology Holdings Inc
22/05/202307:30PR Newswire (US)Creative Medical Technology Holdings Announces Next Milestone Achievements in ImmCelz® Platform DevelopmentNASDAQ:CELZCreative Medical Technology Holdings Inc
18/05/202307:00PR Newswire (US)Creative Medical Technology Holdings Announces Positive Top-Line Study Results for Chronic Lower Back Pain Utilizing its StemSpine® Procedure Using AlloStem™ Allogenic Cell LineNASDAQ:CELZCreative Medical Technology Holdings Inc
12/05/202315:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CELZCreative Medical Technology Holdings Inc
01/05/202315:47Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:CELZCreative Medical Technology Holdings Inc
12/04/202314:30AllPennyStocks.comBiotech Up Massively On Follow-Up DataNASDAQ:CELZCreative Medical Technology Holdings Inc
12/04/202307:00PR Newswire (US)Creative Medical Technology Announces Positive Top-Line Results for Type 2 Diabetes StudyNASDAQ:CELZCreative Medical Technology Holdings Inc
04/04/202307:00PR Newswire (US)Creative Medical Technology Holdings Announces Filing of 2022 Form 10-K and Provides Business UpdateNASDAQ:CELZCreative Medical Technology Holdings Inc
31/03/202315:47Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CELZCreative Medical Technology Holdings Inc
23/03/202307:00PR Newswire (US)Creative Medical Technology Files Orphan Drug Designation Application with the U.S. FDA Using the ImmCelz® Platform for the Treatment of Brittle Type 1 DiabetesNASDAQ:CELZCreative Medical Technology Holdings Inc
21/03/202307:00PR Newswire (US)Creative Medical Technology Holdings Announces Key Milestones Regarding ImmCelz® Platform DevelopmentNASDAQ:CELZCreative Medical Technology Holdings Inc
07/03/202307:00Business WireCreative Medical Technology Holdings Engages Highly Respected International CRO for Phase 1 / 2 Clinical Trial to Treat Type 1 Diabetes Using CELZ-201NASDAQ:CELZCreative Medical Technology Holdings Inc
14/02/202307:00Business WireThree Year Follow-Up Results Confirm Efficacy of StemSpine® Procedure for Treating Chronic Lower Back Pain, with No Serious Adverse EffectsNASDAQ:CELZCreative Medical Technology Holdings Inc
08/02/202307:00PR Newswire (US)Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of Novel Cell Therapy for the Treatment of Type 1 DiabetesNASDAQ:CELZCreative Medical Technology Holdings Inc
03/11/202206:30PR Newswire (US)Creative Medical Technology Holdings Announces FDA Clearance of Investigational New Drug (IND) Application for AlloStem™, a Novel Cell Therapy for the Treatment of Type 1 DiabetesNASDAQ:CELZCreative Medical Technology Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:CELZ

Su Consulta Reciente

CCOM
US500
US 500
NASDAQ
AMZN
Amazon.com
AMEX
XLE
Energy Select Sector SPDR
AMEX
XLF
Financial Select Sector
USOTC
BASFY
BASF (QX)
NYSE
MCD
McDonalds
NASDAQ
GOOGL
Alphabet
NYSE
NKE
Nike
FX
USDMXN
US Dollar vs MXN
USOTC
BNPQY
BNP Paribas (QX)
USI
USTECH100
US Tech 100
NYSE
JPM
JP Morgan Chase
USOTC
ADDYY
Adidas (QX)
COIN
ETHUSD
Ethereum
PM
XAUUSD
Gold vs US Dollar
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados